Alcon Inc.
NYSE:ALCMedical - Instruments & Supplies
+$0.61 today
- Market cap
- $36.15B
- Beta
- 0.70
- P/E (TTM)
- 38.7
- EPS (TTM)
- $1.67
- Dividend yield
- 0.55%
Volume 4.74M
Average 1.91M
ALC Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Alcon Inc.NYSE: ALC
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization dips below year-ago levels
Q3 FY2026 depreciation & amortization of $296M fell 10.5% year over year, behind the +41.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 62.7% from the prior quarter. Over 3 fiscal years it compounded at +5.9% a year.
Context
- Depreciation & amortization amounted to 12.8% of revenue in FY2025, up 0.4 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -10.5% toward the trailing-twelve-month pace of +41.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 1.34B USD
- Year-over-year change
- +8.7%
- 4-year CAGR
- +2.3%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.34B | +8.7% |
| FY2024 | 2024-12-31 | 1.23B | +0.6% |
| FY2023 | 2023-12-31 | 1.22B | +8.7% |
| FY2022 | 2022-12-31 | 1.12B | -7.9% |
| FY2021 | 2021-12-31 | 1.22B | — |
Depreciation & Amortization vs competitors
How ALC compares with its peers on the latest reported figures
- ALC's LTM Sep 2026 depreciation & amortization of $1.84B is the highest of the 8 companies compared; the peer median is $8.6M.
- Its year-over-year change of +41.7% is the highest of 8, against a peer median of +3.8%.
- Depreciation & amortization amounts to 16.9% of revenue for ALC, versus a peer median of 7.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.84B | +41.7% | +5.9% | 16.9% | |
| LTM Jun 2026 | $411M | -4.2% | +3.6% | 7.7% | |
| LTM Jul 2026 | $384M | +3.8% | +6.9% | 9.1% | |
| LTM Jun 2026 | $46.44M | +19.7% | +5.6% | 7.6% | |
| LTM Apr 2026 | $8.6M | +7.6% | +24.6% | 3.0% | |
| LTM Mar 2026 | $4.56M | +11.6% | +9.7% | 7.9% | |
| LTM Mar 2026 | $3.32M | +1.7% | — | 2.6% | |
| LTM Mar 2026 | $441K | -24.4% | -27.0% | 0.6% | |
| Peer median (excluding ALC) | $8.6M | +3.8% | +6.3% | 7.6% | |
Competitors are the stored peer set for ALC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 8.29B | 8.72B | 9.46B | 9.91B | 10.4B |
| Cost of Revenue | 3.64B | 3.97B | 4.21B | 4.4B | 4.66B |
| Gross Profit | 4.65B | 4.75B | 5.25B | 5.51B | 5.75B |
| Gross Margin | 56.1% | 54.5% | 55.5% | 55.6% | 55.2% |
| Research & Development | 842M | 702M | 859M | 876M | 990M |
| Selling, General & Admin | 3.08B | 3.07B | 3.21B | 3.25B | 3.45B |
| Operating Expenses | 4.07B | 4.08B | 4.21B | 4.1B | 4.39B |
| Depreciation & Amortization | 1.22B | 1.12B | 1.22B | 1.23B | 1.34B |
| EBITDA | 1.76B | 1.74B | 2.24B | 2.68B | 2.5B |
| EBITDA Margin | 21.2% | 20.0% | 23.7% | 27.0% | 24.0% |
| Operating Income | 580M | 672M | 1.04B | 1.41B | 1.36B |
| Operating Margin | 7.0% | 7.7% | 11.0% | 14.3% | 13.1% |
| Interest Income | 3.01M | 16.52M | 34M | 81.45M | 74M |
| Interest Expense | 120.26M | 138.4M | 189M | 186.18M | 204M |
| Other Income / Expenses | (162M) | (209M) | (207M) | (157M) | (200M) |
| Income Before Tax | 418M | 463M | 832M | 1.26B | 1.16B |
| Pre-Tax Margin | 5.0% | 5.3% | 8.8% | 12.7% | 11.2% |
| Income Tax Expense | 42M | 128M | (142M) | 238M | 180M |
| Net Income | 376M | 335M | 974M | 1.02B | 980M |
| Net Margin | 4.5% | 3.8% | 10.3% | 10.3% | 9.4% |
| EPS (Basic) | 0.77 | 0.68 | 1.98 | 2.06 | 1.99 |
| EPS (Diluted) | 0.76 | 0.68 | 1.96 | 2.05 | 1.98 |
| Weighted Avg Shares | 490M | 491.4M | 493M | 494.4M | 494.95M |
| Weighted Avg Shares (Diluted) | 493.4M | 494.4M | 496.5M | 497.5M | 496.2M |
Alcon Inc.
NYSE:ALC
Intrinsic Alpha fair value
Locked
Current Price
$75.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.